Table 2 HPV genotype distribution according to histological diagnosis

HPV 16 and/or 18

427, 60.8 (57.1–64.5)

24,  72.7 (54.5–86.7)

16, 66.7 (44.7–84.4)

8, 88.9 (51.8–99.7)

24, 72.7 (54.5–86.7)

HVP 16 positive

398, 56.7 (52.9–60.4)

18, 54.5 (36.4–71.9)

14, 58.3 (36.6–77.9)

5, 55.6 (21.2–86.3)

19, 57.6 (39.2–74.5)

HPV 18 positive

36, 5.1 (3.6–7.0)

7, 21.2 (9.0–38.9)

3, 12.5 (2.7–32.4)

4, 44.4 (13.7–78.8)

7, 21.2 (9.0–38.9)

Any type in nonavalent vaccine^c

626, 89.2 (86.6–91.4)

29, 87.9 (71.8–96.6)

23, 95.8 (78.9–99.9)

9, 100.0 (66.4–100.0)

32, 97.0 (84.2–99.9)

Any other IARC oncogenic type not in nonavalent vaccine^c

56, 8.0 (6.1–10.2)

1, 3.0 (0.1–15.8)

1, 4.2 (0.1–21.1)

0, 0.0 (0.0–33.6)

1, 3.0 (0.1–15.8)

Any type not classified as oncogenic by IARC^d

18, 2.6 (1.5–4.0)

0, 0.0 (0.0–10.6)

0, 0.0 (0.0–14.2)

0, 0.0 (0.0–33.6)

0, 0.0 (0.0–10.6)

HPV negative^e

4, 0.6 (1.2–1.5)

1, 3.0 (0.1–15.8)

0, 0.0 (0.0–14.2)

0, 0.0 (0.0–33.6)

0, 0.0  (0.0–10.6)